Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia. It operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. The company engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products based on good manufacturing practice certified cannabis extracts for medical markets. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Sydney, Australia.
Metrics to compare | BOD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBODPeersSector | |
---|---|---|---|---|
P/E Ratio | −14.7x | −6.9x | −0.5x | |
PEG Ratio | −0.15 | −0.01 | 0.00 | |
Price/Book | −0.8x | 1.4x | 2.6x | |
Price / LTM Sales | 1.4x | 12.8x | 3.3x | |
Upside (Analyst Target) | - | 280.6% | 38.7% | |
Fair Value Upside | Unlock | 11.9% | 5.0% | Unlock |